Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD

BACKGROUND: The ability of a long-acting muscarinic antagonist (LAMA) and long-acting beta 2 agonists (LABAs; long-acting bronchodilators, LABDs) with or without inhaled corticosteroids (ICSs) to reduce early readmission in hospitalized patients with COPD is unknown. METHODS: We studied a 5% sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishwakarma, Raju, Zhang, Wei, Kuo, Yong-Fang, Sharma, Gulshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293361/
https://www.ncbi.nlm.nih.gov/pubmed/28203071
http://dx.doi.org/10.2147/COPD.S122354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293361/
https://www.ncbi.nlm.nih.gov/pubmed/28203071
http://dx.doi.org/10.2147/COPD.S122354

Ejemplares similares